Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lynthera Corp
Lexington, Massachusetts, USA
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Lynthera is a pre-clinical stage biotechnology company focused on developing next-generation mRNA-based therapeutics. The company leverages a proprietary lipid nanoparticle (LNP) delivery platform designed to improve the safety and efficacy of nucleic acid medicines. Founded by industry veterans with expertise in mRNA and LNP technology, Lynthera aims to address unmet medical needs in rare genetic diseases through precise protein replacement therapies. The company is headquartered in Lexington, Massachusetts, and is backed by leading life science venture capital firms. Its leadership team includes former executives from Translate Bio and Albireo Pharma, bringing significant experience in drug development and commercialization.
- Therapeutic areas
- Rare Diseases
- Modalities
- mRNA-based drugsLipid nanoparticle delivery therapy
- Industry
- Biotech
Beyond the preview
Go deeper on Lynthera Corp.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lynthera Corp.